Importance of aquaporins in the physiopathology of brain edema

Current Pharmaceutical Design

Volumn 10, Issue 18, 2004, Pages 2153-2161

  Venero, Jose L ^a   Machado, Alberto ^a   Cano, Josefina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Aquaporin; Blood brain barrier; Edema; Hypoxia; Traumatic brain injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; AQUAPORIN; AQUAPORIN 4; AQUAPORIN 5; AQUAPORIN 9; AQUAPORIN INHIBITOR; ARACHIDONIC ACID DERIVATIVE; CALCIUM ION; GLUTAMIC ACID; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; MATRIX METALLOPROTEINASE; PHOSPHATE; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

BRAIN EDEMA; BRAIN INJURY; CAUSE OF DEATH; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CEREBROVASCULAR ACCIDENT; CYTOTOXICITY; DRUG MECHANISM; HUMAN; INTRACRANIAL PRESSURE; LACTIC ACIDOSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION; WATER TRANSPORT;

ANIMALS; AQUAPORINS; BRAIN EDEMA; HUMANS;

EID: 3042589544     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043384150     Document Type: Review

References (93)

1. Go KG. The normal and pathological physiology of brain water. Adv Tech Stand Neurosurg 1997; 23: 47-142.
2. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, et al. Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998; 78: 247-306.
3. Agre P, King LS, Yasui M, Guggino WB, Ottersen OP, Fujiyoshi Y, Engel A, Nielsen S. Aquaporin water channels - frorn atomic structure to clinical medicine. J Physiol. 2002 542: 3-16.
4. Denker BM, Smith BL, Kuhajda FP, Agre P. Identification, purification, and partial characterization of a novel Mr 28, 000 integral membrane protein from erythrocytes and renal tubules. J Biol Chem 1988; 263: 15634-42.
5. Preston GM, Agre P. Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. Proc Natl Acad Sci USA 1991; 88: 11110-4.
6. Preston GM, Jung JS, Guggino WB, Agre P. The mercury-sensitive residue at cysteine 189 in the CHIP28 water channel. J Biol Chem 1993; 268: 17-20.
7. Preston GM, Jung JS, Guggino WB, Agre P. Membrane topology of aquaporin CHIP. Analysis of functional epitope-scanning mutants by vectorial proteolysis. J Biol Chem 1994; 269(3): 1668-73.
8. Jung JS, Preston GM, Smith BL, Guggino WB, Agre P. Molecular structure of the water channel through aquaporin CHIP. The hourglass model. J Biol Chem 1994; 269: 14648-54.
9. Agre P, Bonhivers M, Borgnia MJ. The aquaporins, blueprints for cellular plumbing systems. J Biol Chem 1998; 273: 14659-62.
10. Venero JL, Vizuete ML, Machado A, Cano J. Aquaporins in the central nervous system. Prog Neurobiol 2001; 63: 321-36.
11. Badaut J, Lasbennes F, Magistretti PJ, Regli L. Aquaporins in brain: distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab 2002; 22: 367-78.
12. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997; 17: 171-80.
13. Tsukaguchi H, Shayakul C, Berger UV, Mackenzie B, Devidas S, Guggino WB, et al. Molecular characterization of a broad selectivity neutral solute channel. J Biol Chem 1998; 273: 24737-43.
14. Venero JL, Vizuete ML, Ilundain AA, Machado A, Echevarria M, Cano J. Detailed localization of aquaporin-4 messenger RNA in the CNS: preferential expression in periventricular organs. Neuroscience 1999; 94: 239-50.
15. Elkjaer M, Vajda Z, Nejsum LN, Kwon T, Jensen UB, Amiry-Moghaddam M, et al. Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain. Biochem Biophys Res Commun 2000; 276(3): 1118-28.
16. Badaut J, Hirt L, Granziera C, Bogousslavsky J, Magistretti PJ, Regli L. Astrocyte-specific expression of aquaporin-9 in mouse brain is increased after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2001; 21: 477-82.
17. Yamamoto N, Yoneda K, Asai K, Sobue K, Tada T, Fujita Y, et al. Alterations in the expression of the AQP family in cultured rat astrocytes during hypoxia and reoxygenation. Brain Res Mol Brain Res 2001; 90: 26-38.
18. Nielsen S, Smith BL, Christensen EI, Agre P. Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia. Proc Natl Acad Sci USA 1993; 90: 7275-9.
19. Wu Q, Delpire E, Hebert SC, Strange K. Functional demonstration of Na+-K+-2Cl- cotransporter activity in isolated, polarized choroid plexus cells. Am J Physiol 1998: 275(6 Pt 1): C1565-72.
20. Masseguin C, Corcoran M, Carcenac C, Daunton NG, Guell A, Verkman AS, et al. Altered gravity downregulates aquaporin-1 protein expression in choroid plexus. J Appl Physiol 2000; 88: 843-50.
21. Speake T, Freeman LJ, Brown PD. Expression of aquaporin 1 and aquaporin 4 water channels in rat choroid plexus. Biochem Biophys Acta 2003; 1609: 80-6.
22. Pappius HM. Fundamental aspects of brain edema, in Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology 16, Part I: Tumors of the Brain and Skull, New York, Elsevier, 1974; pp 167-185.
23. Kempski O. Cerebral edema. Serum Nephrol 2001; 21: 303-7.
24. Klatzo I. Presidental address. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol 1967; 26: 1-14.
25. Ropper AH, Shafran B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 1984; J41: 26-9.
26. Ayata C, Ropper AH. Ischaemic brain oedema. J Clin Neurosci 2002; 9: 113-24.
27. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53: 309-15.
28. Pullicino PM, Alexandrov AV, Shelton JA, Alexandrova NA, Smurawska LT, Norris JW. Mass effect and death from severe acute stroke. Neurology 1997; 49: 1090-5.
29. Kochanek PM. Ischemic and traumatic brain injury: pathobiology and cellular mechanisms. Crit Care Med 1993; 21(9 Suppl): S333-5.
30. McIntosh TK, Smith DH, Meaney DF, Kotapka MJ, Gennarelli TA, Graham DI. Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab Invest 1996; 74: 315-42.
31. Heuser D, Guggenberger H. Ionic changes in brain ischaemia and alterations produced by drugs. Br J Anaesth 1985; 57: 23-33.
32. Siesjo BK. Acid-base homeostasis in the brain: physiology, chemistry, and neurochemical pathology. Prog Brain Res 1985; 63: 121-54.
33. Marmarou A. Intracellular acidosis in human and experimental brain injury. J Neurotrauma 1992; 9(Suppl. 2): S551-62.
34. Kraig RP, Petito CK, Plum F, Pulsinelli WA. Hydrogen ions kill brain at concentrations reached in ischemia. J Cereb Blood Flow Metab 1987; 7: 379-86.
35. Staub F, Baethmann A, Peters J, Weigt H, Kempski O. Effects of lactacidosis on glial cell volume and viability. J Cereb Blood Flow Metab 1990; 10: 866-76.
36. Kimelberg HK. Current concepts of brain edema. Review of laboratory investigations. J Neurosurg 1995; 83: 1051-9.
37. Morihata H, Nakamura F, Tsutada T, Kuno M. Potentiation of a voltage-gated proton current in acidosis-induced swelling of rat microglia. J Neurosci 2000; 20: 7220-7.
38. Staub F, Mackert B, Kempski O, Peters J, Baethmann A. Swelling and death of neuronal cells by lactic acid. J Neurol Sci 1993; 119: 79-84.
39. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic - ischemic brain damage. Ann Neurol 1986; 19: 105-11.
40. Nabekura T, Morishima S, Cover TL, Mori S, Kannan H, Komune S, et al. Recovery from lactacidosis-induced glial cell swelling with the aid of exogenous anion channels. Glia 2003; 41: 247-59.
41. Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000; 32: 1-14.
42. Steinhauser C, Gallo V. News on glutamate receptors in glial cells. Trends Neurosci 1996; 19: 339-45.
43. Deitmer JW. Strategies for metabolic exchange between glial cells and neurons. Respir Physiol 2001; 129: 71-81.
44. Sage JI, Van Uitert RL, Duffy TE. Early changes in blood brain barrier permeability to small molecules after transient cerebral ischemia. Stroke 1984; 15: 46-50.
45. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 2002; 200: 629-38.
46. Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci 1999; 22: 11-28.
47. Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury. Arch Neurol 1990; 47: 1245-54.
48. Xiao F. Bench to bedside brain edema and cerebral resuscitation the present and future. Acad Emerg Med 2002; 9: 933-46.
49. Jean WC, Spellman SR, Nussbaum ES, Low WC. Reperfusion injury after local cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery 1998; 43: 1382-96.
50. Shiga Y, Onodera H, Kogure K, Yamasaki Y, Yashima Y, Syozuhara H, et al. Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci Lett 1991; 125: 110-2.
51. Yamasaki Y, Suzuki T, Yamaya H, Matsuura N, Onodera H, Kogure K. Possible involvement of interleukin-1 in ischemic brain edema formation. Neurosci Lett 1992; 142: 45-7.
52. Matsumoto T, Ikeda K, Mukaida N, Harada A, Matsumoto Y, Yamashita J, et al. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest 1997; 77: 119-25.
53. Shukla A, Dikshit M, Srimal RC. Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium. Neuroreport 1995; 6: 1629-32.
54. Calingasan NY, Park LC, Calo LL, Trifiletti RR, Gandy SE, Gibson GE. Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol 1998; 153: 599-610.
55. Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996; 27: 1124-9.
56. Traystman RJ, Kirsch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 1991; 71: 1185-95.
57. Chan PH, Schmidley JW, Fishman RA, Longar SM. Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology 1984; 34(3): 315-20.
58. Chan VT, Zhang DN, Nagaravapu U, Hultquist K, Romero LI, Herron GS. Membrane-type matrix metalloproteinases in human dermal microvascular endothelial cells: expression and morphogenetic correlation. J Invest Dermatol 1998; 111: 1153-9.
59. Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999; 842: 92-100.
60. Hirohata S, Kusachi S, Murakami M, Murakami T, Sano I, Watanabe T, et al. Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction. Heart 1997; 78: 278-84.
61. Chan PH, Fishman RA, Caronna J, Schmidley JW, Prioleau G, Lee J. Induction of brain edema following intracerebral injection of arachidonic acid. Ann Neurol 1983; 13: 625-32.
62. Unterberg A, Wahl M, Hammersen F, Baethmann A. Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid. Acta Neuropathol (Berl) 1987; 73: 209-19.
63. Barbosa-Coutinho LM, Hartmann A, Hossmann KA, Rommel T. Effect of dexamethasone on serum protein extravasation in experimental brain infarcts of monkey: an immunohistochemical study. Acta Neuropathol (Berl) 1985; 65(3-4): 255-60.
64. Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA, et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 1997; 390: 622-5.
65. Davies DC. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 2002; 200: 639-46.
66. Machein MR, Kullmer J, Fiebich BL, Plate KH, Warnke PC. Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors. Neurosurgery 1999; 44: 732-40.
67. Papadopoulos MC, Saadoun S, Davies DC, Bell BA. Emerging molecular mechanisms of brain tumour oedema. Br J Neurosurg 2001; 15: 101-8.
68. Reulen HJ, Tsuyumu M, Tack A, Fenske AR, Prioleau GR. Clearance of edema fluid into cerebrospinal fluid. A mechanism for resolution of vasogenic brain edema. J Neurosurg 1978; 48: 754-64.
69. Pasantes-Morales H, Franco R, Ordaz B, Ochoa LD. Mechanisms counteracting swelling in brain cells during hyponatremia. Arch Med Res 2002; 33: 237-44.
70. Franco R, Torres-Marquez ME, Pasantes-Morales H. Evidence for two mechanisms of amino acid osmolyte release from hippocampal slices. Pflugers Arch 2001; 442: 791-800.
71. Schwartzkroin PA, Baraban SC, Hochman DW. Osmolarity, ionic flux, and changes in brain excitability. Epilepsy Res 1998; 32: 275-85.
72. Vizuete ML, Veneto JL, Vargas C, Ilundain AA, Echevarria M, Machado A, et al. Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury: potential role in brain edema. Neurobiol Dis 1999; 6: 245-58.
73. Schwarez R, Whetsell WO Jr, Mangano RM. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983; 219: 316-8.
74. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000; 6: 159-63.
75. Taniguchi M, Yamashita T, Kumura E, Tamatani M, Kobayashi A, Yokawa T, et al. Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat. Brain Res Mol Brain Res 2000; 78: 131-7.
76. Ke C, Poon WS, Ng HK, Pang JC, Chan Y. Heterogeneous responses of aquaporin-4 in oedema formation in a replicated severe traumatic brain injury model in rats. Neurosci Lett 2001; 301: 21-4.
77. Kiening KL, van Landeghem FK, Schreiber S, Thomale UW, von Deimling A, Unterberg AW, et al. Decreased hemispheric Aquaporin-4 is linked to evolving brain edema following controlled cortical impact injury in rats. Neurosci Lett 2002; 324: 105-8.
78. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, et al. Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998; 78: 247-306.
79. Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res 1991; 567: 274-82.
80. Haussinger D. The role of cellular hydration in the regulation of cell function. Biochem J 1996; 313: 697-710.
81. Katz J, Golden S, Wals PA. Stimulation of hepatic glycogen synthesis by amino acids. Proc Natl Acad Sci USA 1976; 73: 3433-7.
82. Lavoinne A, Baquet A, Hue L. Stimulation of glycogen synthesis and lipogenesis by glutamine in isolated rat hepatocytes. Biochem J 1987; 248: 429-37.
83. Yamamoto N, Yoneda K, Asai K, Sobue K, Tada T, Fujita Y, et al. Alterations in the expression of the AQP family in cultured rat astrocytes during hypoxia and reoxygenation. Brain Res Mol Brain Res 2001; 90: 26-38.
84. Davies DC. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 2002; 200: 639-46.
85. Saadoun S, Papadopoulos MC, Davies DC, Krishna S, Bell BA. Aquaporin-4 expression is increased in oedematous human brain tumours. J Neurol Neurosurg Psychiatry 2002; 72: 262-5.
86. Saadoun S, Papadopoulos MC, Davies DC, Bell BA, Krishna S. Increased aquaporin 1 water channel expression in human brain tumours. Br J Cancer 2002; 87: 621-3.
87. Vajda Z, Promeneur D, Doczi T, Sulyok E, Frokiaer J, Ottersen OP, et al. Increased aquaporin-4 immunoreactivity in rat brain in response to systemic hyponatremia. Biochem Biophys Res Commun 2000; 270: 495-503.
88. Ke C, Poon WS, Ng HK, Lai FM, Tang NL, Pang JC. Impact of experimental acute hyponatremia on severe traumatic brain injury in rats: influences on injuries, permeability of blood-brain barrier, ultrastructural features, and aquaporin-4 expression. Exp Neurol 2002; 178: 194-206.
89. Frigeri A, Nicchia GP, Nico B, Quondamatteo F, Herken R, Roncali L, et al. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice. FASEB J 2001; 15: 90-8.
90. Vajda Z, Pedersen M, Fuchtbauer EM, Wertz K, Stodkilde-Jorgersen H, Sulyok E, et al. Delayed onset of brain edema and mislocalization of aquaporin-4 in dystrophin-null transgenic mice. Proc Natl Acad Sci USA 2002; 99: 13131-6.
91. Banks WA. Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations. Curr Pharm Design 2003; 9(10): 801-9.
92. Bilfinger TV, Stefano GB. The role of protease inhibition with emphasis on the effects of inflammation and vascular immune phenomena. Curr Pharm Design 2002; 8(7): 505-9.
93. Mazure NM, Brahimi-Horn MC, Pouyssegur J. Protein kinases and the hypoxia-inducible factor-1, two switches in angiogenesis. Curr Pharm Design 2003; 9(7): 531-41.